Top 50 Life Science Startup Investors in South Korea (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Korea Investment Partners
VC Fund
|
4 | South Korea, United States, China | Series A, Series B, Seed | Biotechnology, Health Care, Information Technology | $973k–$50M |
|
Korea Technology Finance Corporation
VC Fund
|
4 | South Korea, Russian Federation | Seed, Series A, Series B | Software, Manufacturing, Medical | $383k–$15M |
|
HB Investment
VC Fund
|
3 | South Korea, United States, Vietnam | Series B, Series A | Software, Biotechnology, Artificial Intelligence | $1.8M–$25M |
|
Mirae Asset Venture Investment
VC Fund
|
3 | South Korea, United States, India | Series A, Series B, Seed | Software, Artificial Intelligence, Biotechnology | $789k–$52M |
|
Kakao Ventures
VC Fund
|
3 | South Korea, United States, Indonesia | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $280k–$27M |
|
Industrial Bank of Korea
VC Fund
|
3 | South Korea, United States, China | Series A, Series B, Seed | Software, Artificial Intelligence, Information Technology | $166k–$28M |
|
Series Ventures
VC Fund
|
3 | South Korea, Singapore | Seed, Series A, Venture - Series Unknown | Health Care, Manufacturing, Biotechnology | $86k–$4.4M |
|
Ulmus Investment
VC Fund
|
2 | South Korea, United Kingdom | Series B, Series A, Series C | Biotechnology, Artificial Intelligence, Manufacturing | $4.2M–$63M |
|
Premier Partners
VC Fund
|
2 | South Korea, United States, United Kingdom | Venture - Series Unknown, Series B, Series A | Health Care, Biotechnology, Medical | $2.6M–$172M |
|
Clarevoyant Ventures
VC Fund
|
2 | South Korea | Seed, Series A, Series B | Medical, Health Care, Life Science | |
|
Quantum Ventures Korea
VC Fund
|
2 | South Korea, United States | Series A, Series B, Seed | Artificial Intelligence, Software, Medical | $1M–$30M |
|
BSK Investment
VC Fund
|
2 | South Korea | Series A, Series B, Series C | Biotechnology, Software, Health Care | $2.1M–$57M |
|
Ost Investment
VC Fund
|
2 | South Korea | Series A, Seed | Biotechnology, Health Care, Life Science | $1M–$2.7M |
|
Medytox Venture Investment
VC Fund
|
2 | South Korea | Series A, Series B, Seed | Biotechnology, Pharmaceutical, Medical | $4k–$44M |
|
Timepolio Asset Management
VC Fund
|
2 | South Korea, United States, Russian Federation | Series B, Series A, Series C | Biotechnology, Health Care, Manufacturing | $3.4M–$80M |
|
Yuhan Corporation
VC Fund
|
2 | South Korea | Series B, Series C, Corporate Round | Health Care, Biotechnology, Medical | $2k–$40B |
|
Kingo Investment Partners
VC Fund
|
2 | South Korea | Series A, Series C, Series B | Health Care, Biotechnology, Therapeutics | $834k–$45M |
|
Devsisters Ventures
VC Fund
|
2 | South Korea, United States, Russian Federation | Venture - Series Unknown, Series A, Seed | Software, Biotechnology, Gaming | $441k–$11M |
|
UTC Investment Co.
VC Fund
|
2 | South Korea, United States, Japan | Series A, Series B | Biotechnology, Health Care, Medical | $2.3M–$21M |
|
Boditech Med
VC Fund
|
2 | South Korea | Seed, Series A | Life Science, Biotechnology, Medical | $271k–$1.7M |
|
Aju IB Investment
VC Fund
|
2 | South Korea, United States, Japan | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | |
|
Coolidge Corner Investment
VC Fund
|
2 | South Korea, United States, Belgium | Seed, Series A, Series B | Software, Manufacturing, Health Care | $223k–$14M |
|
DSC Investment
VC Fund
|
2 | South Korea, United States, Israel | Series A, Series B, Seed | Artificial Intelligence, Health Care, Biotechnology | $530k–$54M |
|
The Wells Investment
VC Fund
|
2 | South Korea, United States, Singapore | Series A, Series B, Seed | Artificial Intelligence, Apps, Health Care | $289k–$16M |
|
STIC Ventures
VC Fund
|
2 | South Korea, United States, Vietnam | Venture - Series Unknown, Series A, Series B | Biotechnology, Artificial Intelligence, Software | $2M–$47M |
|
Technology Guarantee Fund
VC Fund
|
2 | South Korea, Russian Federation | Seed, Series A, Series B | Health Care, Biotechnology, Manufacturing | $415k–$10M |
|
Daekyo Investment
VC Fund
|
2 | South Korea, United States, Hong Kong | Series A, Seed, Series B | Software, Mobile Apps, Education | $584k–$17M |
|
Yozma Group
VC Fund
|
2 | Israel, United States, South Korea | Series B, Seed | Software, Health Care, Medical | $400k–$59M |
|
HG Initiative
VC Fund
|
2 | South Korea, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $360k–$13M |
|
SJ Investment Partners
VC Fund
|
2 | South Korea, United States, Hong Kong | Series A, Series B, Seed | Biotechnology, Manufacturing, Medical | $547k–$27M |
|
QUAD Investment Management
VC Fund
|
1 | South Korea, United States, Japan | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $847k–$80M |
|
Company K Partners
VC Fund
|
1 | South Korea, United States, Gibraltar | Series A, Series B | Biotechnology, Health Care, Artificial Intelligence | |
|
JNPMEDI Partners
VC Fund
|
1 | South Korea | Seed | Health Care, Life Science, Biotechnology | |
|
Yuanta Investment
VC Fund
|
1 | South Korea, Taiwan, Vietnam | Series B, Series C, Series A | Financial Services, Information Technology, E-Commerce | |
|
Widwin Investment
VC Fund
|
1 | South Korea, United States | Series B, Series C, Series A | Biotechnology, Medical, Health Care | $584k–$47M |
|
Future Science and Technology Holdings
VC Fund
|
1 | South Korea, United States | Seed, Series A | Biotechnology, Health Care, Food and Beverage | $231k–$6.7M |
|
IBK Capital
VC Fund
|
1 | South Korea, United States, India | Series A, Seed, Series B | Health Care, Biotechnology, Information Technology | $436k–$17M |
|
Mirae Asset Capital
VC Fund
|
1 | South Korea, United States, India | Series B, Series A, Seed | Health Care, Biotechnology, Artificial Intelligence | $817k–$105M |
|
SV Investment Corp
VC Fund
|
1 | South Korea, United States, China | Series A, Series B, Seed | Software, Information Technology, Artificial Intelligence | $1.2M–$60M |
|
Korea Omega Investment
VC Fund
|
1 | South Korea, United States, France | Series A, Series B, Seed | Biotechnology, Health Care, Pharmaceutical | $762k–$54M |
|
Meritz Securities
VC Fund
|
1 | South Korea, China | Series C, Series A, Series B | Medical, Biotechnology, Pharmaceutical | $4.7M–$45M |
|
Stonebridge Ventures
VC Fund
|
1 | South Korea, United States, Japan | Series B, Series A, Seed | Artificial Intelligence, Biotechnology, Software | $1M–$15M |
|
Shinhan Venture Investment
VC Fund
|
1 | South Korea, United States, India | Venture - Series Unknown, Series B, Series A | Manufacturing, Health Care, Biotechnology | $1.7M–$78M |
|
Nice Investment Partners
VC Fund
|
1 | South Korea, Japan | Series A, Series B, Seed | Health Care, Information Technology, Software | $437k–$26M |
|
Stick Ventures
VC Fund
|
1 | South Korea | Series B, Series A | Biotechnology, Information Technology, Pharmaceutical | |
|
Kolon Investment
VC Fund
|
1 | South Korea, Indonesia, United States | Series A, Series B | Biotechnology, Software, Pharmaceutical | |
|
G.N. Tech Venture
VC Fund
|
1 | South Korea, United States | Series B, Series A, Series C | Biotechnology, Pharmaceutical, Health Care | |
|
JX Partners
VC Fund
|
1 | South Korea | Series A, Series C, Series B | Biotechnology, Health Care, Aerospace | $5.9M–$37M |
|
Kiwoom Investment
VC Fund
|
1 | South Korea, United States, Japan | Series B, Series A, Series C | Information Technology, Software, Artificial Intelligence | $1.7M–$33M |
|
Partners Investment
VC Fund
|
1 | South Korea, United States, Japan | Series A, Series B, Series C | Biotechnology, Health Care, Software | $2.7M–$98M |
| Access all 169 investors in South Korea Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YGEntertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, China
Investor stats
- Total investments: 520
- Round size: Seed $973k–$10M; Series A $2.2M–$19M; Series B $4.7M–$50M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $60M in 2023
Portfolio highlights
- Zamface — Zamface is an app that makes beauty video.
- Wakebunny — Wakebunny is a company that specializes in IP-based commerce, leveraging intellectual property to create, market, and monetize unique products and experiences. By focusing on the strategic use of copyrights, trademarks, and brand assets, Wakebunny transforms original ideas, characters, and stories into commercially viable offerings across variousplatforms such as e-commerce, digital media, merchandising, and licensing.
- Inovio Pharmaceuticals — INOVIO is advancing novel immunotherapy technologies to reshape the future of treating and preventing infectious diseases and cancer.
Korea Technology Finance Corporation is a South Korea-based fund for small and medium enterprises.
Show more...Investment focus
- Industry: Software, Manufacturing, Medical
- Stage:Seed, Series A, Series B
- Geography: South Korea, Russian Federation
Investor stats
- Total investments: 92
- Round size: Seed $383k–$4.1M; Series A $1.8M–$8.4M; Series B $1.2M–$15M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Leecell — Leecell is a solar cell manufacturing company that produces organic and perovskite thin‑film photovoltaic cells.
- Intergravity — Intergravity is a company that is developing orbital transportation technologies to support the future of in-space activity. Intergravity is to enable a space environment in which mobility, service, and logistics are seamlessly integrated, creating the framework for long-term operations beyond Earth.
- Unmanned Exploration Laboratory — Unmanned Exploration Laboratory manufactures multirotor drones, fixed-wing aircraft, and unmanned vehicles for space exploration.
HB Investment Inc. was founded on November 11, 1999 starting with paid-in Capital of KRW 10 billion.Since its foundation, HB Investment Inc. has been investing small and medium businesses that have the potential for steady growth and profitability and helping the invested companies to grow well by giving various consulting services. As a result,HB Investment Inc.constructed comprehensive portfolio out of various industrial areas, such as game, entertainment, as well as representative high-tech industries related to semiconductor, Internet, LCD, and a smart phone, bio, health care. In addition, HB Investment Inc. has experiences in implementing business Success-fully by organizing several partnership funds for recent years.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Series B, Series A
- Geography: South Korea, United States, Vietnam
Investor stats
- Total investments: 164
- Round size: Series A $1.8M–$15M; Series B $3.6M–$25M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
- Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
- Destin Power — Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology.
Mirae Asset Venture Investment invests in specialized enterprises and provides technology, funding and management consulting.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 336
- Round size: Seed $789k–$14M; Series A $2.3M–$40M; Series B $5M–$52M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely actively investing — fresh fund, raised $118M in 2026
Portfolio highlights
- Nexedge — Nexedge is a wealth management firm that offers investment management, estate planning, and business advisory services.
- IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
- Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
We are an independent subsidiary of Kakao Corp. & the most active, startup-friendly early stage VC of Korea. (Limited Partnerships, not strategic.).
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: South Korea, United States, Indonesia
Investor stats
- Total investments: 393
- Round size: Seed $280k–$4.2M; Series A $988k–$11M; Series B $3.4M–$27M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fresh fund, raised $40B in 2025
Portfolio highlights
- A33 Studio — A-33 Studio team is led by the chief executive officer ‘Kim Dong Sun’ who was in charge of the development, launch and operation of ‘Counter Strike Online’ which is one of the top 3 online FPS games in Korea. The team consists of developers who have worked together for ‘CS Online’ and ‘Combat Arms’ at Nexon, one of the top online game makers in theworld.
- Tect Group — We deliver real beauty based on distinctive brands and innovative marketing solutions, fostering confidence and positivity around the world.
- Sume — Sume provides agent-native video generation APIs and tools for creating avatar-based and UGC-style videos. The company offers Sume Avatar 1.0, a multi-model orchestration system that behaves like a single avatar endpoint for generating talking-head and product-focused clips. Developers use the Sume Developer API and CLI to create reusable avatars,submit structured video generation jobs, track status, and retrieve production-ready media. The platform supports workflows where agents or applications coordinate creative inputs such as avatars, scripts, and product images. Sume for Brands provides an AI creative application that turns product URLs, product assets, and creative direction into ad-ready UGC-style videos. Its services are used for advertising, branded content, and other video-based communication scenarios.
Industrial Bank of Korea (IBK) is committed to honoring its charter of financing small and medium sized enterprises (SMEs). The Bank has extended the scope of its expertise to provide a comprehensive range of financial services to individual customers in a quest to emerge as a leading financial services group. In pursuit of that goal, IBK is makingevery effort to enhance its competitiveness, achieve balanced growth and strengthen its global presence.The Bank employs around 10,000 staff and operates a distribution network of 612 branches including 12 overseas branches. Providing complementary services, the Bank also operates several subsidiaries: IBK Capital Corporation, IBK-SG Asset Management, IBK System Co., Ltd., and IBK Credit Information Corporation. In 2008, IBK Investment & Securities was launched, focused on meeting the needs of SME customers for services such as IPOs and M&As. Moreover, strategic alliance with Korea Investment Holdings enhances product competitiveness and affiliation with the National Post Office promoting easy customer access to IBK banking services.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, China
Investor stats
- Total investments: 313
- Round size: Seed $166k–$4.5M; Series A $2M–$17M; Series B $4.8M–$28M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- BIGC — BIGC is a technology company that offers digital marketing, content creation, and advertising services.
- Gadget Korea — Gadget korea offers data roaming services.
- Flexell Space — FLEXELL SPACE primarily focuses on the development and manufacturing of space solar cells, aiming to provide differentiated products for our customers in the space industry
Series Ventures is an investment company for the beauty care, engineering, healthcare, social platform, and enterprise sectors.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: South Korea, Singapore
Investor stats
- Total investments: 94
- Round size: Seed $86k–$1.9M; Series A $2.9M–$4.4M
- Lead/follow: 69% lead, 31% follow
Portfolio highlights
- TouchMeal — TouchMind (operating as TouchMeal) runs an AI-driven senior foodtech platform that manages professional institutional catering, customized dietary meal planning, and automated ingredient supply chains for nursing homes. The company handles full kitchen management operations, including hygiene standards compliance, staff management, and thedistribution of specialized elderly-friendly food products.
- HD Hi-Tech — HD Hi-Tech is an innovative technology company specializing in AI-powered switchboard safety diagnostic solutions, helping industries improve electrical system reliability, detect faults in real time, and enhance operational safety and efficiency.
- ROBOS — Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical.
Ulmus Investment
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Manufacturing
- Stage:Series B, Series A, Series C
- Geography: South Korea, United Kingdom
Investor stats
- Total investments: 21
- Round size: Series A $4.2M–$63M; Series B $5M–$27M; Series C $8.4M–$37M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — raised $37M in 2024
Portfolio highlights
- Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
- Quantum AI — Quantum AI is an AI data company that offers offline and online data collection and analysis services. Currently, Quantum AI is providing various services centered on the financial sector, including AI document processing automation, intelligent voice consultation, assetization of unstructured financial data based on its own language model, and AIsearch. Utilizing a proprietary AI recognition engine, the company has integrated and analyzed various data sources, including financial documents, customer consultation history, and market news, and have carried out numerous AI data assetization projects for major domestic commercial banks and insurance companies.
- Metal Link — Metal Link is a South Korean company specializing in power energy materials
Premier Partners (프리미어 파트너스) is a Korean domestic funds management company. It provides investment services for individuals and businesses. Premier Partners was established in September 2005 in Seoul, Korea.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Venture - Series Unknown, Series B, Series A
- Geography: South Korea, United States, United Kingdom
Investor stats
- Total investments: 185
- Round size: Series A $2.6M–$15M; Series B $5.8M–$45M; Venture - Series Unknown $15M–$172M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — raised $83M in 2023
Portfolio highlights
- FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
- Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
- Akisostem BioStrategies — Archisostem BioStrategies is a research and development company.
At Clairvoyant Ventures, we believe the most transformative innovations emerge from bold, unconventional ideas. As a venture capital firm specializing in Deep Tech, we invest in disruptive technologies that push the boundaries of science and engineering, redefining industries and shaping the future.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: South Korea
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GenKOre — GenKOre operates as a biotech company, specializing in genetic scissors.
- Dotter — Dotter is a manufacturing company that designs and produces biodegradable optical coherence tomography devices to diagnose and treat cardiovascular diseases. The company also develops next-generation OCT equipment, an optical imaging device that can create a synergy effect when inserting stents.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Quantum Ventures Korea actively invests in companies within the Technology and Bio/Healthcare industries. The firm manages a portfolio of early to growth-stage companies and continues to look for opportunities across a range of company stages.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Medical
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States
Investor stats
- Total investments: 78
- Round size: Seed $1M–$7.6M; Series A $1.5M–$16M; Series B $3.6M–$30M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $34M in 2019
Portfolio highlights
- Wavelord — Wavelord is a semiconductor company founded in 2019 that develops and manufactures gallium nitride (GaN)–based wafers and chips used in power electronics, RF devices, and microLED displays. The company focuses on compound semiconductor technologies, including GaN epitaxial wafers and microLED components, for applications in communications, energy,and display industries.
- Plastal — Plastal is a mechanical and chemical engineering company that offers polymer, metal, and mold injection services. The company specializes in using its core technology required for bonding between metal and plastic resin, mold technology, injection conditions, and milling capabilities, enabling manufacturing companies to avail themselves of theproducts they desire.
- READi Robust Machine — Ready Robust Machine is a company that makes carbon reduction and fuel cost improvement systems.
BSK Investment is a private equity investment company that invests in unlisted companies.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Series C
- Geography: South Korea
Investor stats
- Total investments: 51
- Round size: Series A $2.1M–$57M; Series B $5M–$26M; Series C $15M–$24M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Bunker Kids — Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.
- FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
- BOS Semiconductors — Driving the Future of Automotive, BOS Semiconductors
Ost Investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: South Korea
Investor stats
- Total investments: 5
- Round size: Series A $1M–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pinot Bio — Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.
- G+FLAS Life Sciences — GFLAS Life Sciences, Inc. is poised to disrupt the agricultural biotechnology sector with its pioneering advancements in CRISPR-Cas genome editing technology. Founded by Dr. Sunghwa Choe in 2014, GFLAS has swiftly established itself as a leader in biotech innovation, dedicated to enhancing human health and promoting agricultural sustainabilitythrough cutting-edge genetic engineering solutions. Our flagship innovation, the world's first vitamin D3-enriched tomatoes, addresses a critical market need by transforming the traditional tomato industry. Tomatoes are one of the most consumed vegetables globally, with the US fresh tomato market alone valued at approximately $18 billion annually, assuming an average price of $1.5 per kilogram. The consumer market value is even more substantial, estimated between $27 to $31.5 billion annually. By introducing vitamin D3-enriched tomatoes, GFLAS not only adds significant nutritional value to a staple food product but also creates a unique selling proposition that meets the increasing consumer demand for functional foods. The strategic partnership with Bayer, a global leader in agricultural science, underscores the commercial viability and substantial market potential of our technology. This collaboration has facilitated the transfer of GFLAS's vitamin D3 tomato technology to Bayer Crio Science in the USA, providing a robust pathway for large-scale commercialization and global market penetration. This partnership not only validates our technological prowess but also positions us for significant growth in the global agricultural market. Our vitamin D3-enriched tomatoes offer numerous advantages over traditional vitamin D supplements. They provide a sustainable, plant-based source of vitamin D3, catering to vegans, vegetarians, and individuals with dietary restrictions or limited sun exposure. Unlike vitamin D3 derived from animal sources, our tomatoes are free from the risk of chemical contamination, making them a safer and more natural alternative. Furthermore, incorporating vitamin D3 into a widely consumed food product enhances consumer acceptance and adherence to recommended dietary intakes. The market potential for our innovations is immense. By capturing a significant share of the $18 billion US wholesale tomato market, our vitamin D3-enriched tomatoes can appeal to health-conscious consumers and address the needs of populations at risk of vitamin D deficiency. Additionally, our enhanced CRISPR-Cas technologies offer transformative possibilities across various agricultural applications, positioning GFLAS for sustained growth and profitability. We are now seeking investment to accelerate our expansion and capitalize on the lucrative opportunities within the US market and beyond. Our financial projections indicate substantial growth, with a target of achieving 30% market share within four years. The infusion of capital will support scaling up production, enhancing quality control, and expanding distribution and marketing efforts. GFLAS Life Sciences invites private equity funds and strategic investors to join us in this groundbreaking venture. With our cutting-edge technologies, strong partnerships, and clear market potential, GFLAS is uniquely positioned to deliver substantial returns on investment while making a profound positive impact on global health and sustainability. We look forward to discussing this exciting investment opportunity further and exploring how we can work together to bring our revolutionary products to market.
- Bionetix Therapeutics — Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.
Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Medical
- Stage:Series A, Series B, Seed
- Geography: South Korea
Investor stats
- Total investments: 23
- Round size: Seed $3M–$3.4M; Series A $3.4M–$15M; Series B $4k–$44M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Nex Eye — Nex Eye is an innovative biotechnology firm that offers revolutionary immunotherapy solutions for individuals battling cancer. The company addresses the fundamental reasons behind the failure of immunotherapy, which are influenced by the biology of cancer itself. Utilizing its ON-SMRT® platform based on actual patient data and resistant cancermodels, Nex Eye identifies new immune-evasion targets such as ONCOKINE®. By transforming the approach to tackling immune resistance, the firm is pioneering a new era in cancer therapy by revitalizing the capabilities of the immune system.
- Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
- Inventera Pharmaceuticals — Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.
Timepolio Asset Management is an asset management firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series B, Series A, Series C
- Geography: South Korea, United States, Russian Federation
Investor stats
- Total investments: 86
- Round size: Series A $3.4M–$17M; Series B $5.2M–$24M; Series C $10M–$80M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- HEM Pharma — HEM Pharma is a biotechnology firm that focuses on personalized microbiome healthcare, live biotherapeutic drug (LBP) development, microbiome analysis, and health-functional food manufacturing. The company leverages proprietary microbiome technologies to develop individualized health solutions and next-generation microbiome-based therapeutics. andsupporting personalized microbiome solutions and functional nutrition products. HEM Pharma has expanded internationally through its Japanese subsidiary and global research partnerships.
- The SMC Group — The SMC Group is a social marketing company.
- Next Securities — The Next Generation AI-driven Brokerage Services
Yuhan Co, Ltd. is a South Korean pharmaceutical and chemical company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C, Corporate Round
- Geography: South Korea
Investor stats
- Total investments: 17
- Round size: Series B $13M–$40B; Series C $7.3M–$32M; Corporate Round $2k–$12M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- J INTS BIO — J INTS BIO is a biotechnology company focused on the research and development of anticancer drugs and orphan medicines. The company develops targeted therapies for conditions such as non-small cell lung cancer and solid tumors.
- Kim Cell & Gene — Kimcell & Gene is creating antibody treatments that target resistance.
- Nobo Medicine — Nobo Medicine is a clinical-stage biotech company focused on developing precision therapies for blood cancers and immune-related aging diseases. It uses biomarker-driven drug discovery and translational research to identify targeted treatments, aiming to improve outcomes in oncology and age-associated immune dysfunction through innovative,data-driven biomedical approaches.
Kingo Investment Partners is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Series A, Series C, Series B
- Geography: South Korea
Investor stats
- Total investments: 28
- Round size: Series A $834k–$9.4M; Series B $11M–$20M; Series C $3.2M–$45M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- IMBiologics — IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules.
- Colosseum — Colosseum is a logistics company that provides e-commerce logistics services to various locations.
- PEOPLE & TECHNOLOGY — PEOPLE AND TECHNOLOGY provides DX-based AI solutions on INDOOR GEOLOCATION AND SMART SENSING through its INDOORPLUS+ IoT, Location Based System (LBS) and Real Time Location System (RTLS) platform in the fields of healthcare, manufacturing, defense, smart cities, and the public sector.More than 100 corporate customers in various business sectorssuch as healthcare, banking, manufacturing, retail, energy and public services have already chosen PEOPLE AND TECHNOLOGY to deploy industry grade solutions for employee safety, asset tracking & monitoring, security & access control, flow management and process efficiency. They have gained improvements in productivity and process efficiency while reducing their corporate risks and optimizing their procurement. Since its foundation in 2013, PEOPLE AND TECHNOLOGY has become a leading provider in South Korea and is expanding overseas.
Venture Capital firm in Korea. We are interested in early-stage investment in gaming, healthcare/biotech, IT services and high technology companies.
Show more...Investment focus
- Industry: Software, Biotechnology, Gaming
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: South Korea, United States, Russian Federation
Investor stats
- Total investments: 109
- Round size: Seed $441k–$3.5M; Series A $1.7M–$8.7M; Venture - Series Unknown $7.7M–$11M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $23M in 2023
Portfolio highlights
- Deeply — Deeply is a sound AI specialized in the unmanned surveillance industry. It also develops AI voice analysis technology designed to analyze non-verbal sounds and extract information. They serve city surveillance, infrastructure, military, rail, air, and port systems.
- Red Brick House — Red Brick House is a specialized South Korean indie game publisher dedicated to discovering, supporting, and publishing innovative independent games, helping talented developers bring creative and engaging gaming experiences to players across domestic and global markets.
- AWESOME Entertainment — AWESOME Entertainment is a media and digital content company that provides YouTube content production, influencer and MCN management, advertising and branded content creation, and media commerce services. The comapny supports brands with campaign planning, viral video production, and distribution across multiple social platforms, while alsooffering production outsourcing and partnership services to maximize audience reach and engagement.
Since its incorporation in 1988, UTC Investment has been implementing and developing private equity investments with deep roots in buyout area, diversified human resources, and an impressive track record as a leading global investment firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 130
- Round size: Series A $2.3M–$13M; Series B $4.9M–$21M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Beamworks — Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures.
- CanLab — CanLab is a developer of AI sensors that focuses on creating optical and thermal cameras, as well as real-time image processing platforms for ground, aerial, and marine mobility. Its product offerings include the Vision Camera, Edge AI Platform, Equipment for Thermal Cameras, and Automotive Camera MES.
- AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Boditech Med provides reliable In-Vitro Diagnostic Solutions for everyone at anywhere, and anytime.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: South Korea
Investor stats
- Total investments: 4
- Round size: Seed $271k–$1.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Raywatt — Raywatt is a medical device company developing optical coherence tomography (OCT) imaging systems used for cardiovascular diagnosis. Its technology helps doctors visualize coronary arteries in detail to support evaluation of heart conditions during medical procedures. The company focuses on improving diagnostic imaging tools for interventionalcardiology and enhancing clinical decision-making through improved vessel visualization and data accuracy.
- RexSoft — Company provides Innovative software and services provider specializing in analytics solutions.
- TSD Life Sciences — TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Aju IB Investment is a venture capital firm that offers SMEs with investments and consulting services.Aju IB Investment offers consulting services that focus on business management, tax, accounting, legal, mergers and acquisitions, additional funding, marketing, and technology support.Aju IB Investment was founded in September 1974 and is basedin Seoul, South Korea.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 106
- Lead/follow: no public data
Portfolio highlights
- Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
- Healing Paper — Healing Paper is a mobile healthcare and information technology company.
- Kovis Technology — Kovis Technology is a manufacturer of measurement and inspection equipment intended for global semiconductor and electronic industries.
Coolidge Corner Investment (CCVC) provides Seed and Seed+ funding to the most innovative tech startup companies in Korea. They proudly provide their portfolio companies a customized support in professional incubating, growth hacking, strategy, network and more.
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Seed, Series A, Series B
- Geography: South Korea, United States, Belgium
Investor stats
- Total investments: 114
- Round size: Seed $223k–$2.1M; Series A $891k–$5.4M; Series B $7.2M–$14M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $8.9M in 2017
Portfolio highlights
- Frefins — Frefins is a specialized Rental Transformation (RX) company that generates value by connecting businesses, financial institutions, and consumers.
- Plantner — PLANTNER develops environmentally friendly polymers that utilizes the controlled-release characteristics of alginate, a polymer derived from seaweed, along with natural controlled-release fertilizers to substitute current chemical products. Concurrently, the company is engaged in research and development as well as local field trials in Korea andVietnam. These innovations are directly aimed at promoting low-input sustainable agriculture. The organization is committed to tackling the unsustainable practices prevalent in conventional agriculture through the use of slow-release fertilizers, aspiring to foster eco-friendly advancements rooted in natural materials, beginning with agriculture, which is the cornerstone of the industry. In traditional agricultural settings, the significant loss of chemical fertilizers has resulted in nutrient depletion, leading to soil degradation issues such as acidification. This reduction in soil productivity compels farmers to resort to even greater quantities of chemicals to enhance yields, thereby perpetuating a detrimental cycle of increasing overuse. As a response, coated slow-release fertilizers have been introduced; however, their synthetic polymer coatings have contributed to the buildup of microplastics in the soil, harming the habitats of beneficial microorganisms and generating additional environmental challenges. To mitigate these concerns, ongoing research and development efforts are focused on substituting the conventional coating materials of slow-release fertilizers which are responsible for environmental issues like residual microplastics with alginate, a biodegradable polymer sourced from seaweed.
- Partridge Systems — Partridge Systems develops an automotive data platform that enables real-time data transfer, sharing, and structured data management. The platform offers end-to-end capabilities, including data collection, storage, and deployment pipelines for processing vehicle big data through web-based visualization tools. It allows users to access streamingdata without local downloads and supports seamless collaboration among engineers worldwide.
DSC Investments invests in early stage and growth companies in the field of corporate identify and focus, IT, software, biotechnology, machinery, and future high-growth areas such as environment and resources.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, Israel
Investor stats
- Total investments: 255
- Round size: Seed $530k–$9.1M; Series A $1.6M–$17M; Series B $4.8M–$54M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
- MID — MID specializes in the development, testing, and production of space-related components.
- CarbonSix — CarbonSix delivers cutting-edge robotics automation for manufacturing, combining Six-Sigma robot dexterity and intelligence to transform industrial operations worldwide.
VC, Venture Capital
Show more...Investment focus
- Industry: Artificial Intelligence, Apps, Health Care
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, Singapore
Investor stats
- Total investments: 57
- Round size: Seed $289k–$1.8M; Series A $1.1M–$6.1M; Series B $2.7M–$16M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Milliway — Milliway is an infrastructure digitalization startup that uses vehicle sensor data to detect and manage road damage in real time. It offers solutions for monitoring city and road events and provides tools to enhance productivity in city and road management.
- AIT STUDIO — AIT Studio is a digital health startup that develops AI-powered, contactless gait analysis solutions for early detection of mobility decline and age-related conditions such as sarcopenia. Our flagship products—GAIT Studio (App) and MediStep M Pro (hardware package)—deliver full gait assessments in under 1 minute, without wearables or specializedstaff.
- FLYTO — FLYTO is a South Korean aviation simulation and technology company. The company specializes in building advanced infrastructure for aviation training, aircraft maintenance education, real-flight data integration, and future Advanced Air Mobility (AAM) or Urban Air Mobility (UAM) validation.
STIC Ventures invests in small and mid-sized venture companies with core technologies and new business models.
Show more...Investment focus
- Industry: Biotechnology, Artificial Intelligence, Software
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: South Korea, United States, Vietnam
Investor stats
- Total investments: 152
- Round size: Series A $2M–$44M; Series B $8.8M–$47M; Venture - Series Unknown $3.7M–$17M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $172M in 2013
Portfolio highlights
- Liner — LINER is Asia’s first AI Agent that helps users accomplish more with less time and effort “AI Workspace”, known as the autonomous agent, performs various and complex tasks requested by users using LLM-based AI, differentiated by LINER’s highlighter database. More than 94% of LINER's users are from outside Korea & more than 100 countries.We are reducing our customer’s research time from hundreds of minutes to tens of seconds every day with our product.
- CYTUR — CYTUR is a leader in ship cyber security, support to shipowner and shipbuilder protect their smart-ships against cyber-attacks.
- Pebble Square — Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency.
Technology Guarantee Fund is an investment firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: South Korea, Russian Federation
Investor stats
- Total investments: 39
- Round size: Seed $415k–$4.1M; Series A $1.4M–$7.3M; Series B $6.6M–$10M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- LYNK Solutec — LYNK Solutec is a laboratory-based company that specializes in bio-medical devices.
- Beyond Honeycomb — Beyond Honeycomb is a food-tech company developing an AI-driven kitchen robot solution. Our AI Chef reproduces the texture and taste of the world-class chef’s dish at the molecular level.
- DK Fine Chemical — DK Fine Chemical is committed to providing essential cellulose-based solutions that play a crucial role in various industries, including construction, paint, coatings, food, pharmaceuticals, personal care, and more. The company focuses on delivering high-quality, sustainable, and innovative cellulose compounds, tailored to meet the diverse needs ofits clients across these sectors.
Daekyo Investment is a venture capital firm specialized in development of venture industry.
Show more...Investment focus
- Industry: Software, Mobile Apps, Education
- Stage:Series A, Seed, Series B
- Geography: South Korea, United States, Hong Kong
Investor stats
- Total investments: 69
- Round size: Seed $712k–$13M; Series A $1.7M–$15M; Series B $584k–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- MOAIS — MOAIS develops a smartphone AI solution that analyzes golf swing problem and offers a lesson solution. It is an on-device AI optimized for smart phones, has a video pose estimation, video segmentation, video classification, video object detection, and image processing of golf swing video.
- Redrob — McKinley & Rice is a software development and outsourcing company.
- AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series B, Seed
- Geography: Israel, United States, South Korea
Investor stats
- Total investments: 29
- Round size: Seed $400k–$4.5M; Series B $2.5M–$59M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- RoomGenie — An AI-powered chatbot for hotels revolutionizes the way guests interact with in-room services by enabling seamless cross-selling and upselling. Integrated within smart devices or hotel apps, this AI solution leverages natural language processing (NLP) to communicate with guests in a conversational and personalized manner.From booking spatreatments and restaurant reservations to upgrading rooms or scheduling late checkouts, the chatbot intuitively identifies guest preferences and suggests relevant services. It analyzes data such as guest profiles, previous stays, and real-time behavior to deliver tailored recommendations, boosting both guest satisfaction and revenue.Available 24/7, the chatbot ensures instant responses to guest inquiries, reducing dependence on front-desk staff and enhancing operational efficiency. Additionally, it supports multiple languages, catering to a global clientele and making communication barrier-free. Hotels can integrate the AI chatbot with their property management systems (PMS) and point-of-sale (POS) platforms to streamline service delivery and track guest interactions.The solution empowers hotels to provide a hyper-personalized, tech-forward experience, which appeals to modern travelers. By automating cross-selling and upselling opportunities while improving guest engagement, the chatbot not only enhances the overall stay experience but also drives incremental revenue, making it a vital tool for the hospitality industry.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
- Fine Data Lab — Fine Data Lab is a digital data analysis company offering digital marketing consulting, analytics, and data analytics solutions.
HGI runs an impact-driven business, seeking to address diverse social issues through sustainable innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: South Korea, United States
Investor stats
- Total investments: 49
- Round size: Seed $360k–$7.7M; Series A $1M–$8.2M; Series B $3.8M–$13M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sankun — Sankun is a Seoul-based construction data and AI platform. It connects buyers, vendors, and contractors through databases for projects, bidding, and construction analytics. The company offers enterprise data, site intelligence, and bidding insights, helping firms improve decision-making and streamline construction workflows using real-time data andAI tools.
- Lumora — Lumora is an Independent Power Producer (IPP) specializing in transforming idle land into renewable energy assets by developing, owning, and operating sustainable power generation projects that maximize land value while supporting clean energy production.
- Dolbom-ui-sin — Caregiver is a specialized platform operator that provides hospitals with advanced nursing solutions, streamlining patient care coordination, enhancing clinical workflows, and supporting specialized nursing practices through intelligent tools and integrated digital systems.
SJ Investment Partners is a venture capital firm that invests in the IT and biotechnology industries.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Medical
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, Hong Kong
Investor stats
- Total investments: 78
- Round size: Seed $547k–$2.7M; Series A $1.6M–$12M; Series B $4.5M–$27M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- DevD — DevD is a startup that provides 1:1 customized content and recommendation services based on self-developed lifestyle AI algorithms.
- Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
- Eleven O'Clock — Eleven O'Clock is a space management platform that offers non-face-to-face cleaning of accommodation facilities. The company's platform Keeper innovates space operation and management as the new standard for space management. The efficiency and quality of space management are improved according to the systematic manual of the Keeperplatform. The platform records and communicates every process as data, from management manuals to space status checks.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Established in 2009, QUAD is an independent investment manager overseeing approximately US$1.0 billion in equity assets (as of June 2019). Our clients range from institutional clients such as pension funds, endowments and family offices to individual parents and their children. All investment managers and key management being equity partners of thefirm, QUAD members are significant investors in the company, which we believe aligns our goals with the interests of our clients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 21
- Round size: Series A $847k–$23M; Series B $4M–$80M; Series C $15M–$75M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- HoneyNaps — Connected Family through Digital Healthcare.Beginning in 2015, HoneyNaps began to develop the element technology for monitoring Bio-signal and completed the platform launch. In order to derive full-cycle bio-signal management & the disease prediction model.
- NeoCannBio — NeoCannBio provides natural product processing facilities for generating new medications derived from natural goods and built a cannabinoid library of hemp, and medical cannabis.
- KaliVir Immunotherapeutics — multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. LEARN MORE NEWS AND EVENTSAugust 19, 2026 - KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing READ MORE November 19, 2025 - KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate
Company K Partners Limited is a principal investment firm specializing in investments in culture content, electronic components, computer, machinery, broadcasting, arts, sports, and leisure industries. The firm primarily invests in South Korea with a focus in Seoul, Gyeongnam, and Gyeonggi. Company K Partners Limited was established in 2006 and isbased in Gyeonggi-do, South Korea.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Series A, Series B
- Geography: South Korea, United States, Gibraltar
Investor stats
- Total investments: 147
- Lead/follow: no public data
Portfolio highlights
- Qunova Computing, Inc. — Quantum computing based computing innovations for new materials and drug discovery, and advanced technology solution consulting services.
- HydroXpand — HydroXpand is an innovative developer and manufacturer specializing in the design and production of anion exchange membrane (AEM) electrolysis stacks, which are key components in the efficient and sustainable production of hydrogen through water electrolysis.
- Illimis Therapeutics — We translate cutting-edge science into innovative medicine
JNPMEDI Partners links investors and life sciences companies looking for funding, giving investors clear performance reports and opportunities for companies to obtain capital.
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed
- Geography: South Korea
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Kim Cell & Gene — Kimcell & Gene is creating antibody treatments that target resistance.
A star of private equity market grow up your companies and ascend your potential.
Show more...Investment focus
- Industry: Financial Services, Information Technology, E-Commerce
- Stage:Series B, Series C, Series A
- Geography: South Korea, Taiwan, Vietnam
Investor stats
- Total investments: 35
- Lead/follow: no public data
Portfolio highlights
- MediMabBio — Creating therapeutic opportunities for the most serious diseases.
- Selta Square — Selta Square is an AI-based drug monitoring company that provides full-cycle drug monitoring solutions using artificial intelligence technology.
- Pin Therapeutics — Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA.* Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assaycascade for molecular glue degrader screening* Programs - Selective Molecular Glue Degrader (CK1α) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed)
Widwin Investment is an investment firm.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series B, Series C, Series A
- Geography: South Korea, United States
Investor stats
- Total investments: 16
- Round size: Series A $4.2M–$8.4M; Series B $584k–$47M; Series C $6.3M–$46M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Rodwin — Rodwin is a transportation management company specializes in vehicle consignment transportation services.
- SMALL MACHINES — SMALL MACHINES specializes in the production of AI-driven medical diagnostic analyzers. The company focuses on the development of Cardiac Point Of Care Testing (POCT) devices specifically designed for use in emergency rooms. Additionally, it offers Lab-on-a-Chip OEM/ODM services and is engaged in the creation of digital healthcare platforms.
- PineTree Therapeutics — PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Future Science and Technology Holdings is an investment company that specializes in technology-based services.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Food and Beverage
- Stage:Seed, Series A
- Geography: South Korea, United States
Investor stats
- Total investments: 35
- Round size: Seed $231k–$1.7M; Series A $2.2M–$6.7M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Caretive —
- Protier Biotech — PROTIER Biotech is a company leading the development of therapeutics through innovative biotechnology .
- ArcGen Bioscience — Embark on a Voyage in Immuno-Oncology
IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: South Korea, United States, India
Investor stats
- Total investments: 118
- Round size: Seed $436k–$4M; Series A $1.8M–$11M; Series B $3M–$17M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- BEYLESS — BEYLESS is an embedded platform for autonomous driving.
- IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
- MID — MID specializes in the development, testing, and production of space-related components.
Mirae Asset Capital Market is a leading global investment banking, securities and institutional business firm that provides a wide range of financial services to a substantial and diversified client base.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Series B, Series A, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 148
- Round size: Seed $817k–$18M; Series A $3.1M–$47M; Series B $8.4M–$105M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
- Higgsfield — The ultimate AI-powered camera control for creators by creators
- Bunker Kids — Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.
SV Investment Corp is a venture capital firm that provides companies with finance, strategic advice and information at critical stages of their development.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, China
Investor stats
- Total investments: 111
- Round size: Seed $1.2M–$31M; Series A $2.7M–$36M; Series B $7.5M–$60M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- CarbonSix — CarbonSix delivers cutting-edge robotics automation for manufacturing, combining Six-Sigma robot dexterity and intelligence to transform industrial operations worldwide.
- Linq — We are creating ‘hyper-automated insurance platforms’ to comprehensively support underwriters and claim adjusters and to facilitate communication between insurers and reinsurers using AI and deep learning.
- KaliVir Immunotherapeutics — multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. LEARN MORE NEWS AND EVENTSAugust 19, 2026 - KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing READ MORE November 19, 2025 - KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate
Korea Omega Investment Finance is a private equity and venture capital firm
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, France
Investor stats
- Total investments: 39
- Round size: Seed $762k–$1.5M; Series A $3.7M–$15M; Series B $5.8M–$54M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- ActionFit — ActionFit is a video game company with expertise in developing and publishing video games for the mobile platform.
- Esol — Esol operates a semiconductor equipment business focused on extreme ultraviolet (EUV) technology. It provides EUV pellicle transmittance and mask phase measurement systems, as well as interference patterning equipment, enabling higher-resolution, denser, and more advanced semiconductor chips.
- Brenus Pharma — Brenus Pharma develops off-the-shelf, next-generation in vivo immunotherapies designed to unlock the immune response against solid tumors.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Securities, Investment, Finance, Trading company
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Stage:Series C, Series A, Series B
- Geography: South Korea, China
Investor stats
- Total investments: 12
- Round size: Series A $4.7M–$8.2M; Series B $16M–$22M; Series C $18M–$45M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
- LDCarbon Co. — LD Carbon manufactures recycled resource materials designed to reduce carbon dioxide emissions. The company's eco-friendly material is manufactured by refining, processing, and commercializing combustion residues from combustion residues gas, oil, and steel that are generated through pyrolysis after crushing waste tires, enabling clients torecycle resource materials that reduce emissions, use crude oil resources, and solve environmental problems caused by waste tires for a sustainable future.
- Lanvin Group — Lanvin group is a fashion industry that oversees the labels lanvin, caruso, wolford, sergio rossi, and st. John knits. It is offering this assistance along with in-depth information about and connection to the fashion markets.
Stonebridge Ventures was founded in 2008
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, Software
- Stage:Series B, Series A, Seed
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 35
- Round size: Seed $1M–$2.7M; Series A $1.3M–$14M; Series B $3.5M–$15M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Michelo Robotics — PORTAL301 is a tech startup focused on transforming the UI/UX in the robotics industry. It focus is on the nuclear power plant decommissioning and powder coating sectors.
- Narnia Labs — Narnia Labs is the developer of artificial intelligence-based design software designed to provide domain-based three-dimensional synthetic data. The company's software provides design creation, evaluation, optimization, and recommendation services, enabling clients from engineering and industrial design fields to develop performance bycollaborating with AI, from manufacturing to architecture, medicine, and the metaverse.
- Labrador Labs — LABRADOR LABS began as an academic research collaboration initiative to develop an automated analytic method for detecting both known and new vulnerabilities.
Shinhan Venture Investment operates as an investment company. Shinhan Venture Investment focuses on earlier-stage venture capital investments and later-stage control investments opportunities derived from the latest megatrends such as the aging population, disruptive technologies, IT convergence, alternative energy and etc.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Series B, Series A
- Geography: South Korea, United States, India
Investor stats
- Total investments: 235
- Round size: Series A $2.5M–$26M; Series B $4.5M–$45M; Venture - Series Unknown $1.7M–$78M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
- Return Zero — AI, ASR, Diarization, Speech, ML
- Linq — We are creating ‘hyper-automated insurance platforms’ to comprehensively support underwriters and claim adjusters and to facilitate communication between insurers and reinsurers using AI and deep learning.
NICE Investment Partners is a new technology finance company whose main job is to increase corporate value by discovering and investing in new technology businesses with promising growth, providing various management support, business alliances, and strategic consulting to the invested companies.
Show more...Investment focus
- Industry: Health Care, Information Technology, Software
- Stage:Series A, Series B, Seed
- Geography: South Korea, Japan
Investor stats
- Total investments: 58
- Round size: Seed $437k–$1.9M; Series A $2.1M–$26M; Series B $4.8M–$16M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Pensées — Pensées is a 3D bio-printer company that develops cultured meat through 3D bioprinting technology.
- FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
- Motif Technologies — Motif Technologies is an AI deep tech company that develops proprietary AI models and provides optimized cloud infrastructure for AI deployment, from everyday personal use to enterprise-scale applications.
Stick Ventures is a venture capital firm based in South Korea that prefers to invest in seed-stage, early-stage, and later-stage companies.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Pharmaceutical
- Stage:Series B, Series A
- Geography: South Korea
Investor stats
- Total investments: 38
- Lead/follow: no public data
Portfolio highlights
- Robros — Robros is constantly creating technology to break through the barrier between people and robots in order to build a world in which everyone in the service industry can live a physically and emotionally happy life.
- Ettifos — Ettifos provides flexible, reliable, and innovative V2X solutions to enable communication between all stakeholders on the road.
- Imagoworks — Imagoworks Inc. offers a Web-based Dental CAD solution using AI, streamlining the digital workflow for dental professionals. Together with world-class technology, we are setting new standards for digital dentistry in the global market. Our mission is to <Making the future of digital medicine for everyone>.While we have accumulatedtechnological expertise in the medical field for over 10 years, specializing in AI-based automation, 3D geometric modeling and mesh processing, and software as a service (SaaS), we now turn our focus to commercializing our innovative technologies and transforming the field of digital dentistry. By cooperating with and licensing to leading global dental companies, we are seeing great success as we find ourselves in the industry spotlight.Imagoworks currently offers Dentbird Crown which automatically generates optimal crown designs with a single click and without any software installation required. As we continue to expand our services, Imagoworks aims to be recognized as a chairside design solution for dentists worldwide.
Kolon Investment, Inc. is a venture capital and private equity firm specializing in buyouts, mezzanine, corporate restructuring, growth capital, and turnaround investment. It prefers to invest in electronic components, petroleum, energy, computer, and telecommunications equipment. The firm primarily invests in South Korea with a focus in Seoul,Gyeonggi, Incheon, and Gyeongbuk. Kolon Investment, Inc. was established in 2000 and is based in Seoul, South Korea.Source: Businessweek
Show more...Investment focus
- Industry: Biotechnology, Software, Pharmaceutical
- Stage:Series A, Series B
- Geography: South Korea, Indonesia, United States
Investor stats
- Total investments: 95
- Lead/follow: no public data
Portfolio highlights
- Boosterz — Boosterz is a company that supports the 5Ps of marketing at all stages, from product planning and launch to growth.
- ActionFit — ActionFit is a video game company with expertise in developing and publishing video games for the mobile platform.
- SCBIO — SCBIO is a pharmaceutical company that makes drugs with specialized technologies in immuno-oncology. The company discovers and develops novel therapeutics for future medicine.
G.N. Tech Venture is a corporate investment company that invests in electronic components.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series B, Series A, Series C
- Geography: South Korea, United States
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- MIRI.DIH — MIRI.DIH is a technology-intensive e-business company.
- Panmnesia — Innovate AI Infrastructure with Panmnesia's Link Solution. Empowering true composability in modern AI infrastructure.
- Meissa — Meissa is a drone-based construction tech startup that provides real-time 3D mapping and modeling.
JX Partners is a venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Aerospace
- Stage:Series A, Series C, Series B
- Geography: South Korea
Investor stats
- Total investments: 12
- Round size: Series A $5.9M–$8.4M; Series B $10M–$11M; Series C $7.2M–$37M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nexusbe — Nexusbe is a manufacturer of atomic layer equipment technology intended to provide vacuum deposition equipment.
- Polaris3D — SMAR AI AMR logistics robot. Achieve smart factory automation and dark factories with zero facility changes, space constraints, or development burdens.
- Specs — Specs offer satellite data analysis services using advanced 3D hyperspectral technology and develop satellite-mounted observation equipment. Specs plans to commercialize hyperspectral technology for Earth observation, transforming 3D astronomical spectroscopy into high-precision satellite data collection and analysis, ensuring high-qualitysatellite data.
Kiwoom Investment provides financial assistance with funding for small businesses.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series B, Series A, Series C
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 113
- Round size: Series A $1.7M–$14M; Series B $4.2M–$21M; Series C $11M–$33M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- GraphAI — GraphAI AI enables seamless integration of diverse data sources for fast and user-friendly AI-powered Business Intelligence (BI).GraphAI-A leverages neural networks to maintain a comprehensive graph view and swiftly reveals valuable insights from enterprise data, facilitating trend analysis and a 360-degree customer perspective. This is achievedthrough In-DB AI technology with an intuitive low-code interface.GraphAI-T delivers accelerated and robust BI analytics by leveraging the valuable insights obtained from GraphAI-A. It further facilitates transaction processing on business data through structured queries like SQL and Cypher.
- But Beautiful — A collaborative AI workspace, built on your company context. Build and orchestrate agents right alongside your team's projects, meetings, and connected apps.
- Featuring — Featuring’s goal is to make it easy for anyone to see and utilize the power of influencers. Today, as companies are accelerating their transition to digital business due to COVID-19, the number of companies leveraging The number of influencers is explosively increasing. Featuring allows brands and marketers to discover product-fit influencers andhelps matching based on their needs. Currently, over 3,600 brands are using Featuring, and more than 8,500 influencer campaigns have been done. As a Korea-based startup, Featuring plans on expanding the business to Far East Asia, including Japan and China.
As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Series C
- Geography: South Korea, United States, Japan
Investor stats
- Total investments: 131
- Round size: Series A $2.7M–$30M; Series B $5.5M–$98M; Series C $7.4M–$87M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely still investing — raised $190M in 2023
Portfolio highlights
- XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
- Solivis — Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time.
- Remember & Company — Remember & Company develops professional networking, recruitment, and business relationship management services through its Remember platform and related enterprise solutions. The company provides digital business card management tools that allow users to scan, organize, and update professional contact information through mobile applicationsand cloud-based systems. It also operates recruitment and headhunting services that connect companies with experienced professionals through talent discovery, scouting, and hiring workflows.Remember & Company develops expert network and research services that link businesses with industry specialists for interviews, surveys, and market insight projects. The platform includes community, networking, and business engagement features designed to support professional interaction and relationship-building among working professionals. In addition, Remember & Company offers advertising, corporate marketing, and business solution services targeted toward professional and enterprise audiences.
Life Science Investor funding in South Korea at a glance
Stats across 144 deals from 169 investors.
Access all 169 investors in South Korea Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in South Korea investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 169 investors investing in South Korea Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!